[The treatment of dermatomycoses].
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D003881:Dermatomycoses; D006219:Halogens; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use*; D009181:Mycoses; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D014309:Tripelennamine / Q000627:therapeutic use*
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local; D006219:Halogens; D006846:Hydrocarbons, Halogenated; D000644:Quaternary Ammonium Compounds; D014309:Tripelennamine
ANTISEPTICS, HALOGEN/therapeutic use; ANTISEPTICS, QUATERNARY AMMONIUM/therapeutic use; FUNGUS DISEASES; TRIPELENNAMINE/therapeutic use
Zur Behandlung der Dermatomykosen.